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A number of pre-operative factors predicting nodal burden in women with breast cancer have recently 
been identified. The aim of this study is to assess if these factors independently influence nodal 
burden in women with a positive axillary core biopsy. 
 
Methods: 
All node positive patients detected on axillary core biopsy were identified in our cancer audit 
database. Mode of presentation, age, core tumour grade, core tumour type, ER and HER2 status were 
evaluated. Tumours were assessed for ultrasound (US) size, distance of tumour-to-skin, presence of 
invasion of skin and diffuse skin thickening. Axillary lymph nodes were assessed for cortical 
thickness and presence of US replaced nodes. Statistical significance was ascertained using univariate 
logistic regression. A predictive model was produced following a multiple logistic regression model 
incorporating cross validation and assessed using receiving operating characteristic (ROC) curve. 
 
Results: 
115 patients’ data were analysed. Patients referred because of symptoms (70%vs38%, p=0.005), and 
those with US skin thickening (87%vs59%, p=0.055) have higher nodal burden than those referred 
from screening or without skin thickening. These factors were significant after multivariate analysis. 
The final predictive model included mode of presentation, US tumour size, cortical thickness and 
presence of US skin thickening. The area under curve (AUC) is 0.77. 
 
Conclusion:  
We have shown that mode of presentation and US skin thickening are independent predictors of high 
nodal burden at surgery. A model has been developed to predict nodal burden pre-operatively, which 
may lead to avoidance of ANC in patients with lower nodal burden.  
 
Advances in knowledge: Method of presentation and skin involvement/proximity to skin by the 
primary tumour are known to influence outcome and nodal involvement respectively but have not 
been studied with regard to nodal burden. We have shown that mode of presentation and skin 
thickening at US are independent predictors of high nodal burden at surgery. 

















A number of pre-operative factors predicting nodal burden in women with breast cancer have recently 
been identified. The aim of this study is to assess if these factors independently influence nodal burden 
in women with a positive axillary core biopsy. 
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Around 50% of patients with axillary node metastases from breast cancer have these diagnosed pre-
operatively [1]. It is known that pre-operative node positive patients are found to possess higher nodal 
burden of disease compared to patients diagnosed surgically on sentinel lymph node biopsy (SLNB) [2, 
3]. However, a significant number of patients with a pre-operative diagnosis of axillary metastases also 
have a low nodal burden [4]. 
 
Current standard practice is for patients with a positive pre-operative axillary core biopsy to proceed 
directly to axillary node clearance (ANC). As ANC is associated with high morbidity, there is an 
increasing move to steer away from ANC where there is no survival advantage to patients [5, 6]. 
Evidence from a landmark randomised trial (ACOSOG Z0011) has shown that not all node positive 
patients require ANC [7]. In women with a low burden of axillary disease i.e. one or two positive lymph 
nodes positive on SLNB, the AMAROS trial has shown that axillary radiotherapy provides comparable 
axillary control to ANC and with a lower morbidity [5, 8] It would be advantageous therefore, to know 
preoperatively which patients with a diagnosis of axillary metastasis were likely to have a high or low 
burden of disease in order to guide planning of surgical procedures.  
 
Two recent studies have shown that preoperative factors associated with high nodal burden with 
independent significance include the number of abnormal nodes seen on US and the node cortical 
morphology on US [9,10].  Other factors which were significant on univariate analysis but not were not 
significant on multivariate analysis included needle biopsy (fine needle aspiration or core needle 
biopsy) was performed (p<0.0001), presence of effacement of fatty hilum (p<0.0001), larger breast 
tumour size measured on US (p<0.0001), reported abnormal LN maximum cortical thickness 
(p=0.0002), higher tumour grade (p=0.0001), presence of lymphovascular invasion (p=0.0038) and 
positive HER2 (p=0.0262) [9]; larger US short diameter (SD) of axillary lymph nodes (p=0.009), 
presence of MRI cortical morphological changes (p<0.001), larger MRI SD (p=0.025) and long 
diameter (LD) (p=0.036) of axillary lymph nodes [10].   The study by Kim et al had a number of 












































































nodal burden, (ii) not all patients with positive axillae underwent ANC to determine the total number 
of positive nodes and (iii) only two-thirds (312 out of 451 patients) of patients had US meaning the 
results are liable to bias [10].  The low nodal burden group included patients who were node negative 
as well as those with 1-2 nodes positive.   The study by Lim et al again included women who were node 
negative in the low burden group but the study did include a large number of women with a high nodal 
burden and all women with positive axillae appeared to have had ANC [9].   
 
Recent studies have shown that skin involvement and a short distance from the tumour to the skin are 
associated with high rates of nodal involvement [11, 12].  These studies did not, however, look at the 
nodal burden in those patients with axillary metastases. A number of studies have shown that measuring 
breast skin thickness is accurate and reproducible [13, 14]. Screening detection is associated with a 
good outcome even when other pathological variables are taken into account.  This is reflected in the 
widely used PREDICT score takes patient source of referral into account [15]. Neither of these two 
previous studies looked at presence of diffuse skin thickening or patient source at predicting nodal 
burden. 
 
The aims of this study are, therefore, to assess pre-operative predictors of nodal burden specifically in 
those women who have positive axillary core biopsies (the first study to do so) and to see if US skin 
involvement and patient source of referral are associated with nodal burden.  
 
Methods 
A retrospective search of our local electronic cancer audit database for all node positive patients 
detected on axillary core biopsy between the 1st January 2014 and 31st December 2016 was carried 
out. Ethical approval was obtained. Exclusion criteria were patients who had on axillary core biopsy 
disease which on a node excision would be categorised as isolated tumour cells or micrometastatic 
disease. Patients who underwent neoadjuvant chemotherapy, neoadjuvant endocrine therapy or those 












































































of 62 (range 38-90) who proceeded to ANC after they were found to have nodal metastasis on core 
biopsy. This was standard local practice during the time frame of this study.  
 
The preoperative factors assessed included mode of presentation (screen-detected versus symptomatic), 
patient’s age, tumour grade on core, tumour type on core, ER status and HER2 status. There was a 
retrospective review of ultrasound (US) images of the primary tumour and axillary lymph node. This 
was performed by an experienced radiologist who was blinded to the number of positive lymph nodes 
found on pathological assessment of the ANC specimen. The US images of the primary tumours were 
assessed for US size, distance of tumour to skin, presence of direct invasion of skin and presence of 
diffuse skin thickening over the tumour. The US images of the axillary lymph nodes were assessed for 
cortical thickness and the presence of replaced nodes (absence of the hilum). It was not possible to 
accurately estimate the number of abnormal nodes seen on US in this retrospective study. 
 
The level of nodal burden at ANC was defined as low if 1-2 nodes were involved and heavy if 3 or 
more nodes were involved with macrometastases (>2mm). We considered the skin to be thickened if it 
was above 2.5mm at US. Figure 1 demonstrates measurement of skin thickness on US [16]. Figure 2 
shows US images of radiological skin invasion of the tumour. 
 
The association between the level of nodal burden and each of the candidate risk factors were initially 
assessed by performing univariate logistic regression before fitting the 12 candidate factors into the 
multiple logistic regression model with outcome as the level of nodal burden at ANC (defined as low if 
1-2 nodes and heavy if 3 or more nodes). Statistical programme used to perform statistical analysis 




One hundred and fifteen patients proceeded to ANC after they were found to have nodal metastasis on 












































































38-90). 43 (37%) patients had 1-2 nodes positive (Group A) while 72 (63%) patients had 3 or more 
nodes positive (Group B). Patient characteristics in relation to nodal burden are presented in Table 2. 
 
Mode of presentation 
Patients referred through breast screening had a lower frequency of high nodal burden compared to 
women with symptoms (10/26 (38%) vs. 62/ 89 (70%) respectively, p=0.005). 
 
Core biopsy 
Patients with HER2 negative disease had a significantly lower frequency of high nodal burden (51/91 
(56%) vs. 21/24 (81%), p= 0.032). Core tumour grade and ER status did not predict nodal burden. Core 
biopsy characteristics in relation to nodal burden are presented in Table 2. 
 
Imaging factors 
 A subgroup of 50 patients have had their imaging reviewed by a second radiologist. The results are 
shown in Table 1. This confirms the excellent reproducibility of the metrics used.  All US were carried 
out by 6 radiologists and 1 advanced practitioner of more than 5 years of experience of breast and 
axillary US performed the scan using the same model of US machine. 
i. US images of the primary tumours 
Smaller US tumour size (p=0.009) was significantly associated with a low frequency of high nodal 
burden. The presence of US skin thickening has a borderline association with high nodal burden. 13/15 
(87%) vs 59/100 (59%) p=0.055.  Direct skin invasion at US was not associated with heavier node 
positivity. Imaging factors in relation to nodal burden are presented in Table 3. 
ii. US images of the axillary lymph nodes 
Thinner LN cortical thickness (p= 0.002) was associated with a low frequency of high nodal burden. 
The percentage of patients with a high nodal burden was 33.3% for 2-3mm, 48.0% for 3.1-4mm and 
68.2% for 4.1-5mm and 75.0% for >5mm. The presence of replaced nodes was not associated with a 













































































Final predictive model 
Table 4 gives the odds ratios for the factors in the final predictive model. Those factors maintaining 
independent significance were mode of presentation, US skin thickening, US tumour size and US node 
cortical thickness.  The discriminatory power for the final predictive model was c = 0.77 (sensitivity = 
0.51, specificity = 0.81). The ROC curve is shown in Figure 3. 
 
Discussion 
ANC has been utilised as the standard treatment for axillary metastasis in breast cancer for many years. 
It was not until recently that practices have changed in light of influential clinical trials such as 
AMAROS and ACOSOG Z0011. The AMAROS trial was the first study to suggest that ANC is not 
needed in all patients with positive nodes. At 6.1 median years’ follow up, there were no significant 
differences in the 5- year overall survival (93.3% vs 92.5%), disease-free survival (86.9% vs 82.7%) or 
loco-regional recurrences (0.43% vs 1.19%) between patients with T1-T2 breast cancer and no more 
than 2 positive SLNs, who were randomised to ANC versus axillary radiotherapy [8]. There was twice 
as much morbidity (i.e. lymphoedema) associated with ANC [8]. Authors of the ACOSOG Z0011 
study, concluded that in patients with 1-2 nodes positive treated with breast conservation surgery, the 
use of sentinel node biopsy alone may be adequate and these patients may not require ANC [7]. In that 
randomised trial, female patients with T1-T2 breast cancer undergoing wide local excision and 
radiotherapy with no palpable lymphadenopathy and no more than 2 positive sentinel lymph nodes 
(SLNs) were randomised to ANC versus no further axillary surgery and at 9.3 median years there was 
no difference in overall survival (86.3% vs 83.6%; p=0.02) between the two groups. Similarly, there 
was no difference in disease-free survival (80.2% vs 78.2%; p= 0.32) or regional recurrence (83.0% vs 
81.2%; p= 0.41) [17]. These trials, therefore, demonstrated that patients with limited axillary metastasis 
could avoid ANC without compromising overall survival and loco-regional outcomes. 
 
In this study, we have found patients mode of presentation and US skin thickening are preoperative 












































































preoperative diagnosis of axillary metastasis on core biopsy, we also found US tumour size and US 
cortical thickness to be independent predictors of nodal burden. 
 
Two recent studies have shown that the number of US abnormal axillary nodes and US node 
morphology (including cortical thickness) are also independently associated with high nodal burden at 
ANC.  As cortical thickness is a continuous variable, the cut off value used to prompt biopsy can be 
adjusted upwards to ensure a reduction in the pre-operative diagnosis of nodal metastases in women 
with low nodal burden. As only one-third of patients has a cortical thickness of less than 3mm have a 
high nodal burden, ANC clearance in this group may represent overtreatment. This data also supports 
using a 3mm cut-off for biopsy for abnormal nodes. The two previous studies differed from our current 
study as they included node negative women in the low nodal burden group, whilst our current study is 
the first to look at predictors of nodal burden in women with positive axillary core biopsies only and is 
the first study from a European Breast centre. 
 
Regarding US skin thickening, all clinical inflammatory cancers were excluded from this study, and 
these cases in this study did not have clinically apparent skin thickening. Previous studies have 
identified that the distance from the tumour to the skin is related to nodal metastases but we did not find 
this significant in our study [18]. The presence of skin thickening is postulated to be due to skin oedema 
secondary to lymphatic obstruction by tumour cells. The high rate of nodal metastases is probably as a 
result of tumour entering the florid dermal lymphatic and venous plexuses.  Such a mechanism of 
tumour dissemination has long been established in malignant melanoma [19, 20, 21]. 
 
More importantly, we have found that patient mode of presentation is an independent predictor of nodal 
burden even when other factors such as US tumour size are taken into account.  The reason for this is 
unclear.  This finding is however similar to the previous studies showing that screen detection is an 














































































Multiple nomograms and scoring systems have been developed to help predict the risk of metastases in 
non-sentinel lymph nodes in patients with a positive sentinel lymph node. These include the Memorial 
Sloan-Kettering Cancer Centre, MD Anderson Cancer Center, Stanford, Tenon and Saidi nomograms 
and scoring systems [24, 25].  The two recent studies of preoperative prediction of nodal burden in 
women with a positive axillary core biopsy found that number of abnormal nodes was a strong predictor. 
The number of abnormal nodes at axillary US could not be assessed in this retrospective analysis. Using 
the factors identified in our study a predictive model gives an AUC of 0.77. This is the same as one the 
studies which included the number of abnormal nodes on US.  This suggests that a model including the 
number of abnormal nodes and the factors we have identified should give a model with an even better 
performance. A prospective, multi-centre study would be useful in confirming the validity of this 
approach before clinical practice can change.  
 
Conclusion 
The present study showed that US skin thickening, mode of referral, US tumour size and US cortical 
thickness are independently associated with nodal burden found on ANC in patients with a pre-
operative diagnosis of axillary metastasis on core biopsy. When these factors added to the number of 
abnormal nodes on US, a model could be constructed to predict nodal burden pre-operatively, leading 
to an avoidance of ANC in patients with a lower nodal burden. 
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Fig. 1 US image demonstrates US skin thickening. The bold white arrow measures more than 2.5mm 


















































Table 1. USS results reproducibility 
USS parameters Agreement/ICCC 
Replaced node 0.80* 
Skin thickening 0.86* 
Skin involvement 0.96* 
ICCC cortical thickness   0.94** 
ICCC distance to skin   0.90** 
ICCC tumour size   0.77** 
 
*Agreement 












Table 2. Patient Characteristics  
* P values are obtained from t-test for age and from Chi-squared test for tumour grade, tumour type, 
ER. 
** Included in the final predictive model 
 
Patient Characteristics 
Group A  
(1-2 node(s)) 
(n = 43) 
Group B 
(≥ 3 nodes) 




Age in years (median with IQR) 60 (49-69) 64 (54-74) 
1.02  




Screening 16 (62%) 10 (38%) -- -- 
Symptom 27 (30%) 62 (70%) 
3.67  
(1.48 – 9.13) 
0.005 
Tumour grade 
1 or 2 19 (40%) 28 (60%) -- -- 
3 24 (35%) 44 (65%) 
1.24  
(0.58 – 2.68) 
0.576 
Tumour type 
IDC 32 (34%) 63 (66%) -- -- 
Lobular 8 (47%) 9 (53%) 
0.57  
(0.20 – 1.62) 
0.293 
Other 3 (100%) 0 (0%) 
0.00  
(0.00 - Inf) 
0.990 
ER status 
Positive 35 (41%) 51 (59%) 
0.56  
(0.22 – 1.39) 
0.210 
Negative 8 (28%) 21 (72%) -- -- 
Her2 status 
Positive 3 (15%) 17 (85%) 
4.12  
(1.13 – 15.02) 
0.032 











Table 3. Imaging factors. 
Imaging Factors 
Group A  
(1-2 node(s)) 
(n = 43) 
Group B 
(≥ 3 nodes) 




























0 (0%) 1 (1%) 
  
Distance from 





(3.1 – 8.0) 
4.3 
(1.5 – 6.9) 
0.93  
(0.83 – 1.03) 
0.164 
Presence of direct 
invasion of skin 
Yes 5 (33%) 10 (67%) 
1.23  
(0.39 – 3.86) 
0.728 
No 38 (38%) 62 (62%) -- -- 
Presence of US skin 
thickening** 
Yes 2 (13%) 13 (87%) 
4.52  
(0.97 – 21.09) 
0.055 
No 41 (41%) 59 (59%) -- -- 
Replaced node 
Yes 17 (29%) 42 (71%) 
2.14  
(0.99 – 4.63) 
0.053 
No 26 (46%) 30 (54%) -- -- 
* P values are obtained from Wilcoxon rank sum test for USS tumour size, USS cortical thickness, and 
distance from tumour to skin, and from Chi-squared test for presence of direct invasion of skin, presence 
of diffuse skin thickening, and replaced node. 











Table 4. Final predictive model for the level of nodal burden (high vs low). 
Variables Coefficient estimate Adjusted OR (95% CI) 
Mode of 
presentation 
Screening*  -- 
Symptom 0.927 2.53 (0.88 – 7.25) 
USS tumour size  0.067 1.07 (1.02 – 1.13) 
USS cortical thickness 0.314 1.37 (1.09 – 1.72) 
Presence of diffuse 
skin thickening 
Yes 2.280 9.78 (1.01 – 94.62) 
No*  -- 
*Criterion for references 
 
